MOH — authorised 8 November 2013
- Marketing authorisation holder: SUNOVION PHARMS INC
- Status: likely_approved
MOH authorised Aptiom on 8 November 2013
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 8 November 2013.
SUNOVION PHARMS INC holds the UAE marketing authorisation.